biochemistry and medicine background information in pharmacology
AB123 belongs to a novel neuropharmacological class of molecules called beta-C kinins. Beta-C kinins enhance the production of brain derived neurotrophic factor (BDNF). BDNF is normally produced throughout life in the entorhinal cortex which is involved with cognition and memory. In Alzheimers disease its production is diminished. The intended clinical indication for AB123 is the amelioration of cognitive dysfunction associated with Alzheimers disease (AD).
write a background information on the disease, Beta-C kinins and brain derived neurotrophic factor (BDNF) and their improvement on cognitive function on such patients, find out their relation by looking into journals from previous literature (latest)
AB123 belongs to a novel neuropharmacological class of molecules called beta-C kinins. Beta-C kinins enhance the production of brain derived neurotrophic factor (BDNF). BDNF is normally produced throughout life in the entorhinal cortex which is involved with cognition and memory. In Alzheimers disease its production is diminished. The intended clinical indication for AB123 is the amelioration of cognitive dysfunction associated with Alzheimers disease (AD).
write a background information on the disease, Beta-C kinins and brain derived neurotrophic factor (BDNF) and their improvement on cognitive function on such patients, find out their relation by looking into journals from previous literature (latest)
Need a Professional Writer to Work on this Paper and Give you a 100 % Original Paper? Click Here and Get this Essay Done………………
No comments:
Post a Comment
Note: only a member of this blog may post a comment.